178 related articles for article (PubMed ID: 28927276)
1. Alkoxycarbonate Ester Prodrugs of Preclinical Drug Candidate ELQ-300 for Prophylaxis and Treatment of Malaria.
Frueh L; Li Y; Mather MW; Li Q; Pou S; Nilsen A; Winter RW; Forquer IP; Pershing AM; Xie LH; Smilkstein MJ; Caridha D; Koop DR; Campbell RF; Sciotti RJ; Kreishman-Deitrick M; Kelly JX; Vesely B; Vaidya AB; Riscoe MK
ACS Infect Dis; 2017 Oct; 3(10):728-735. PubMed ID: 28927276
[TBL] [Abstract][Full Text] [Related]
2. ELQ-300 prodrugs for enhanced delivery and single-dose cure of malaria.
Miley GP; Pou S; Winter R; Nilsen A; Li Y; Kelly JX; Stickles AM; Mather MW; Forquer IP; Pershing AM; White K; Shackleford D; Saunders J; Chen G; Ting LM; Kim K; Zakharov LN; Donini C; Burrows JN; Vaidya AB; Charman SA; Riscoe MK
Antimicrob Agents Chemother; 2015 Sep; 59(9):5555-60. PubMed ID: 26124159
[TBL] [Abstract][Full Text] [Related]
3. Atovaquone and ELQ-300 Combination Therapy as a Novel Dual-Site Cytochrome bc1 Inhibition Strategy for Malaria.
Stickles AM; Smilkstein MJ; Morrisey JM; Li Y; Forquer IP; Kelly JX; Pou S; Winter RW; Nilsen A; Vaidya AB; Riscoe MK
Antimicrob Agents Chemother; 2016 Aug; 60(8):4853-9. PubMed ID: 27270285
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of Deuterated Endochin-Like Quinolones.
Pou S; Winter RW; Liebman KM; Dodean RA; Nilsen A; DeBarber A; Doggett JS; Riscoe MK
J Labelled Comp Radiopharm; 2024 May; 67(5):186-196. PubMed ID: 38661253
[TBL] [Abstract][Full Text] [Related]
5. ELQ-331 as a prototype for extremely durable chemoprotection against malaria.
Smilkstein MJ; Pou S; Krollenbrock A; Bleyle LA; Dodean RA; Frueh L; Hinrichs DJ; Li Y; Martinson T; Munar MY; Winter RW; Bruzual I; Whiteside S; Nilsen A; Koop DR; Kelly JX; Kappe SHI; Wilder BK; Riscoe MK
Malar J; 2019 Aug; 18(1):291. PubMed ID: 31455339
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of cytochrome bc1 as a strategy for single-dose, multi-stage antimalarial therapy.
Stickles AM; Ting LM; Morrisey JM; Li Y; Mather MW; Meermeier E; Pershing AM; Forquer IP; Miley GP; Pou S; Winter RW; Hinrichs DJ; Kelly JX; Kim K; Vaidya AB; Riscoe MK; Nilsen A
Am J Trop Med Hyg; 2015 Jun; 92(6):1195-201. PubMed ID: 25918204
[TBL] [Abstract][Full Text] [Related]
7. Quinolone-3-diarylethers: a new class of antimalarial drug.
Nilsen A; LaCrue AN; White KL; Forquer IP; Cross RM; Marfurt J; Mather MW; Delves MJ; Shackleford DM; Saenz FE; Morrisey JM; Steuten J; Mutka T; Li Y; Wirjanata G; Ryan E; Duffy S; Kelly JX; Sebayang BF; Zeeman AM; Noviyanti R; Sinden RE; Kocken CHM; Price RN; Avery VM; Angulo-Barturen I; Jiménez-Díaz MB; Ferrer S; Herreros E; Sanz LM; Gamo FJ; Bathurst I; Burrows JN; Siegl P; Guy RK; Winter RW; Vaidya AB; Charman SA; Kyle DE; Manetsch R; Riscoe MK
Sci Transl Med; 2013 Mar; 5(177):177ra37. PubMed ID: 23515079
[TBL] [Abstract][Full Text] [Related]
8. Aminoalkoxycarbonyloxymethyl Ether Prodrugs with a pH-Triggered Release Mechanism: A Case Study Improving the Solubility, Bioavailability, and Efficacy of Antimalarial 4(1
Monastyrskyi A; Brockmeyer F; LaCrue AN; Zhao Y; Maher SP; Maignan JR; Padin-Irizarry V; Sakhno YI; Parvatkar PT; Asakawa AH; Huang L; Casandra D; Mashkouri S; Kyle DE; Manetsch R
J Med Chem; 2021 May; 64(10):6581-6595. PubMed ID: 33979164
[TBL] [Abstract][Full Text] [Related]
9. Optimization of endochin-like quinolones for antimalarial activity.
Winter R; Kelly JX; Smilkstein MJ; Hinrichs D; Koop DR; Riscoe MK
Exp Parasitol; 2011 Feb; 127(2):545-51. PubMed ID: 21040724
[TBL] [Abstract][Full Text] [Related]
10. Targeted Structure-Activity Analysis of Endochin-like Quinolones Reveals Potent Qi and Qo Site Inhibitors of Toxoplasma gondii and Plasmodium falciparum Cytochrome bc
McConnell EV; Bruzual I; Pou S; Winter R; Dodean RA; Smilkstein MJ; Krollenbrock A; Nilsen A; Zakharov LN; Riscoe MK; Doggett JS
ACS Infect Dis; 2018 Nov; 4(11):1574-1584. PubMed ID: 30117728
[TBL] [Abstract][Full Text] [Related]
11. Mitochondrial type II NADH dehydrogenase of Plasmodium falciparum (PfNDH2) is dispensable in the asexual blood stages.
Ke H; Ganesan SM; Dass S; Morrisey JM; Pou S; Nilsen A; Riscoe MK; Mather MW; Vaidya AB
PLoS One; 2019; 14(4):e0214023. PubMed ID: 30964863
[TBL] [Abstract][Full Text] [Related]
12. Generation of quinolone antimalarials targeting the Plasmodium falciparum mitochondrial respiratory chain for the treatment and prophylaxis of malaria.
Biagini GA; Fisher N; Shone AE; Mubaraki MA; Srivastava A; Hill A; Antoine T; Warman AJ; Davies J; Pidathala C; Amewu RK; Leung SC; Sharma R; Gibbons P; Hong DW; Pacorel B; Lawrenson AS; Charoensutthivarakul S; Taylor L; Berger O; Mbekeani A; Stocks PA; Nixon GL; Chadwick J; Hemingway J; Delves MJ; Sinden RE; Zeeman AM; Kocken CH; Berry NG; O'Neill PM; Ward SA
Proc Natl Acad Sci U S A; 2012 May; 109(21):8298-303. PubMed ID: 22566611
[TBL] [Abstract][Full Text] [Related]
13. Subtle changes in endochin-like quinolone structure alter the site of inhibition within the cytochrome bc1 complex of Plasmodium falciparum.
Stickles AM; de Almeida MJ; Morrisey JM; Sheridan KA; Forquer IP; Nilsen A; Winter RW; Burrows JN; Fidock DA; Vaidya AB; Riscoe MK
Antimicrob Agents Chemother; 2015 Apr; 59(4):1977-82. PubMed ID: 25605352
[TBL] [Abstract][Full Text] [Related]
14. Discovery, synthesis, and optimization of antimalarial 4(1H)-quinolone-3-diarylethers.
Nilsen A; Miley GP; Forquer IP; Mather MW; Katneni K; Li Y; Pou S; Pershing AM; Stickles AM; Ryan E; Kelly JX; Doggett JS; White KL; Hinrichs DJ; Winter RW; Charman SA; Zakharov LN; Bathurst I; Burrows JN; Vaidya AB; Riscoe MK
J Med Chem; 2014 May; 57(9):3818-34. PubMed ID: 24720377
[TBL] [Abstract][Full Text] [Related]
15. A prodrug form of a Plasmodium falciparum glutathione reductase inhibitor conjugated with a 4-anilinoquinoline.
Davioud-Charvet E; Delarue S; Biot C; Schwöbel B; Boehme CC; Müssigbrodt A; Maes L; Sergheraert C; Grellier P; Schirmer RH; Becker K
J Med Chem; 2001 Nov; 44(24):4268-76. PubMed ID: 11708927
[TBL] [Abstract][Full Text] [Related]
16. Prodrugs of reverse fosmidomycin analogues.
Brücher K; Gräwert T; Konzuch S; Held J; Lienau C; Behrendt C; Illarionov B; Maes L; Bacher A; Wittlin S; Mordmüller B; Fischer M; Kurz T
J Med Chem; 2015 Feb; 58(4):2025-35. PubMed ID: 25633870
[TBL] [Abstract][Full Text] [Related]
17. Identification, design and biological evaluation of bisaryl quinolones targeting Plasmodium falciparum type II NADH:quinone oxidoreductase (PfNDH2).
Pidathala C; Amewu R; Pacorel B; Nixon GL; Gibbons P; Hong WD; Leung SC; Berry NG; Sharma R; Stocks PA; Srivastava A; Shone AE; Charoensutthivarakul S; Taylor L; Berger O; Mbekeani A; Hill A; Fisher NE; Warman AJ; Biagini GA; Ward SA; O'Neill PM
J Med Chem; 2012 Mar; 55(5):1831-43. PubMed ID: 22364416
[TBL] [Abstract][Full Text] [Related]
18. Progress in the Optimization of 4(1
Brockmeyer F; Manetsch R
Chimia (Aarau); 2017 Apr; 71(4):213-219. PubMed ID: 28446339
[TBL] [Abstract][Full Text] [Related]
19. 3-Position Biaryl Endochin-like Quinolones with Enhanced Antimalarial Performance.
Pou S; Winter RW; Dodean RA; Liebman K; Li Y; Mather MW; Nepal B; Nilsen A; Handford MJ; Riscoe TM; Laxson S; Kirtley PJ; Aleshnick M; Zakharov LN; Kelly JX; Smilkstein MJ; Wilder BK; Kortagere S; Vaidya AB; Alday PH; Doggett JS; Riscoe MK
ACS Infect Dis; 2024 Jun; ():. PubMed ID: 38862127
[TBL] [Abstract][Full Text] [Related]
20. Disulfide prodrugs of albitiazolium (T3/SAR97276): synthesis and biological activities.
Caldarelli SA; Hamel M; Duckert JF; Ouattara M; Calas M; Maynadier M; Wein S; Périgaud C; Pellet A; Vial HJ; Peyrottes S
J Med Chem; 2012 May; 55(10):4619-28. PubMed ID: 22591034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
